KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Inovio Pharmaceuticals (INO) Times Interest Earned (2019 - 2024)

Inovio Pharmaceuticals' Times Interest Earned history spans 6 years, with the latest figure at -$177.05 for Q1 2024.

  • For Q1 2024, Times Interest Earned fell 26.28% year-over-year to -$177.05; the TTM value through Dec 2024 reached -$632.05, down 436.93%, while the annual FY2024 figure was -$632.05, 436.93% down from the prior year.
  • Times Interest Earned for Q1 2024 was -$177.05 at Inovio Pharmaceuticals, down from -$97.03 in the prior quarter.
  • Across five years, Times Interest Earned topped out at -$9.0 in Q1 2020 and bottomed at -$332.19 in Q2 2022.
  • The 5-year median for Times Interest Earned is -$118.16 (2023), against an average of -$128.94.
  • The largest annual shift saw Times Interest Earned skyrocketed 79.3% in 2020 before it crashed 1429.38% in 2021.
  • A 5-year view of Times Interest Earned shows it stood at -$27.47 in 2020, then crashed by 699.62% to -$219.67 in 2021, then increased by 18.76% to -$178.46 in 2022, then soared by 45.63% to -$97.03 in 2023, then crashed by 82.47% to -$177.05 in 2024.
  • Per Business Quant, the three most recent readings for INO's Times Interest Earned are -$177.05 (Q1 2024), -$97.03 (Q4 2023), and -$113.41 (Q3 2023).